Daniël Blockmans

16.4k total citations · 3 hit papers
190 papers, 7.7k citations indexed

About

Daniël Blockmans is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Daniël Blockmans has authored 190 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 81 papers in Rheumatology and 40 papers in Genetics. Recurrent topics in Daniël Blockmans's work include Vasculitis and related conditions (81 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (30 papers) and Otitis Media and Relapsing Polychondritis (28 papers). Daniël Blockmans is often cited by papers focused on Vasculitis and related conditions (81 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (30 papers) and Otitis Media and Relapsing Polychondritis (28 papers). Daniël Blockmans collaborates with scholars based in Belgium, Netherlands and United States. Daniël Blockmans's co-authors include Luc Mortelmans, Herman Bobbaers, Steven Vanderschueren, Wolfgang Schmidt, Bhaskar Dasgupta, Elisabeth Brouwer, Carlo Salvarani, Alex Maes, Hans Deckmyn and Sigrid Stroobants and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Daniël Blockmans

179 papers receiving 7.5k citations

Hit Papers

Trial of Tocilizumab in Giant-Cell Arteritis 2017 2026 2020 2023 2017 2018 2025 250 500 750

Peers

Daniël Blockmans
Comparison fields: 5 of 126
  • Pulmonary and Respiratory Medicine 4.7k
  • Rheumatology 4.1k
  • Physiology 1.3k
  • Genetics 1.3k
  • Surgery 948
Replace Bernhard Hellmich with:
Bernhard Hellmich Germany
Gail S. Kerr United States
Xavier Puéchal France
Kenneth J. Warrington United States
C. G. M. Kallenberg Netherlands
Elisabeth Brouwer Netherlands
Lorraine Harper United Kingdom
María C. Cid Spain
E. Christiaan Hagen Netherlands
Carlos García‐Porrúa Spain
Bernhard Hellmich Germany View profile →
Citations per field, relative to Daniël Blockmans
Daniël Blockmans · 1×
Citations per year, relative to Daniël Blockmans
Daniël Blockmans · 1×

Countries citing papers authored by Daniël Blockmans

Since Specialization
Citations

This map shows the geographic impact of Daniël Blockmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël Blockmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël Blockmans more than expected).

Fields of papers citing papers by Daniël Blockmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniël Blockmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël Blockmans. The network helps show where Daniël Blockmans may publish in the future.

Co-authorship network of co-authors of Daniël Blockmans

This figure shows the co-authorship network connecting the top 25 collaborators of Daniël Blockmans. A scholar is included among the top collaborators of Daniël Blockmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniël Blockmans. Daniël Blockmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 3
3 0
4 4
5 4
6 1
7 24
8 5
9 10
10 10
11 1
12
Trial of Tocilizumab in Giant-Cell Arteritis breakdown →
815
13
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A PATIENT WITH WHIM SYNDROME AND PANCYTOPENIA
1
14 1
15
Efficacy and safety of a protocol-based treatment of severe early diffuse systemic sclerosis (dSSc) using mycophenolate mofetil (MMF) in combination with intravenous methylprednisolone (IV MP) pulses.
1
16
From prolonged febrile illness to fever of unknown origin. The challenge continues
11
17
De ziekte van Wegener
1
18
Commercially available intravenous immunoglobulins (iv igs) inhibit binding of anti-glycoprotein (gp)iib-iiia antibodies to their antigens in chronic idiopathic thrombocytopenic purpura (itp) patients
1
19
Naar een internationaal vergelijkbare maatstaf voor de orale antistollingstherapie
0
20
Influence of products of the cyclo-oxygenase pathway on platelet shape change
4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026